These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1271242)

  • 1. Editorial: Dissolution test blossoms.
    Feldmann EG
    J Pharm Sci; 1976 Apr; 65(4):I. PubMed ID: 1271242
    [No Abstract]   [Full Text] [Related]  

  • 2. Dissolution test acceptance sampling plans.
    Tsong Y; Hammerstrom T; Lin K; Ong TE
    J Biopharm Stat; 1995 Jul; 5(2):171-83. PubMed ID: 7581426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter: USP content uniformity test.
    Madan PL
    J Pharm Sci; 1976 Jan; 65(1):VIII. PubMed ID: 1255410
    [No Abstract]   [Full Text] [Related]  

  • 4. Uniformity of content requirements for tablets and capsules.
    Kendall CE; Low GK; Hailey DM
    J Pharm Pharmacol; 1981 Apr; 33(4):197-202. PubMed ID: 6115899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "In vitro" dissolution tests for solid oral dosage forms.
    Rees JE
    Boll Chim Farm; 1977 Sep; 116(9):499-505. PubMed ID: 597400
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro evaluation of physiological availability of compressed tablets.
    Wood JH
    Pharm Acta Helv; 1967 Mar; 42(3):129-51. PubMed ID: 4870534
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison between the U.S.P. 18 and the wet sieving disintegration tests.
    Sandell E; Helmstein I
    Acta Pharm Suec; 1971 Nov; 8(5):549-52. PubMed ID: 5159524
    [No Abstract]   [Full Text] [Related]  

  • 8. High failure rate of the dissolution tests for 500-mg amoxicillin capsules sold in Cambodia: is it because of the product or the test method?
    Okumura J; Taga M; Tey S; Kataoka Y; Nam N; Kimura K
    Trop Med Int Health; 2010 Nov; 15(11):1340-6. PubMed ID: 20958889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New in vitro disintegration and dissolution test method for tablets and capsules.
    Goodhart FW; McCoy RH; Ninger FC
    J Pharm Sci; 1973 Feb; 62(2):304-10. PubMed ID: 4686409
    [No Abstract]   [Full Text] [Related]  

  • 10. Probability of passing dissolution acceptance criteria for an immediate release tablet.
    Dumont ML; Berry MR; Nickerson B
    J Pharm Biomed Anal; 2007 May; 44(1):79-84. PubMed ID: 17379465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborative study of the USP dissolution test for prednisone tablets with Apparatus 2.
    Cox DC; Furman WB
    J Pharm Sci; 1984 May; 73(5):670-6. PubMed ID: 6737242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle size limits to meet USP content uniformity criteria for tablets and capsules.
    Rohrs BR; Amidon GE; Meury RH; Secreast PJ; King HM; Skoug CJ
    J Pharm Sci; 2006 May; 95(5):1049-59. PubMed ID: 16552749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
    Strauch S; Jantratid E; Dressman JB
    J Pharm Pharmacol; 2009 Mar; 61(3):331-7. PubMed ID: 19222905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dissolution profiles of tablets and capsules from the USP, Levy, and magnetic basket methods.
    Needham TE; Luzzi LA
    J Pharm Sci; 1974 Jun; 63(6):925-8. PubMed ID: 4851107
    [No Abstract]   [Full Text] [Related]  

  • 15. International harmonization of generic drugs: in vitro dissolution tests for Japanese and American generic tablets.
    Otsuka M; Tomita H; Otsuka K; Kamae I; Jorgenson JA
    Biomed Mater Eng; 2006; 16(2):129-35. PubMed ID: 16477121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical analysis of the USP 18 content uniformity sampling plan for tablets.
    Langenbucher F
    Pharm Acta Helv; 1972; 47(2):142-52. PubMed ID: 5024143
    [No Abstract]   [Full Text] [Related]  

  • 17. A mini review of scientific and pharmacopeial requirements for the disintegration test.
    Donauer N; Löbenberg R
    Int J Pharm; 2007 Dec; 345(1-2):2-8. PubMed ID: 17935916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for uniformity: sampling plans in pharmacopeias for weight, volume, and content uniformity.
    Pietra V; Setnikar I
    J Pharm Sci; 1970 Apr; 59(4):530-5. PubMed ID: 5440682
    [No Abstract]   [Full Text] [Related]  

  • 19. Stability of nitroglycerin tablets submitted by U.S. hospitals.
    Crabbs WC; Dow ML; Juhl YH; Page DP
    Am J Hosp Pharm; 1983 Dec; 40(12):2170-5. PubMed ID: 6419589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of defect rate.
    Wagner JG
    J Pharm Sci; 1973 Aug; 62(8):VI. PubMed ID: 4725204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.